Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.

Infection and immunity - 1 Jun 2008

Arenas-Gamboa Angela M, Ficht Thomas A, Kahl-McDonagh Melissa M, Rice-Ficht Allison C

Abstract excerpt

The development of safe and efficacious immunization systems to prevent brucellosis is needed to overcome the disadvantages of the currently licensed vaccine strains that restrict their use in humans. Alginate microspheres coated with a protein of the parasite Fasciola hepatica (vitelline protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Bacterial Vaccines
Share to Brucella melitensis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brucellosis

Share to Delayed-Action Preparations

Share to Immunization

Share to Injections, Intraperitoneal

Share to Vaccines, Attenuated

Source

Open in PubMed Open full text

Identifiers

PMID: 18362129
DOI: 10.1128/IAI.00767-07
PMCID: PMC2423109

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18362129-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.PMID 18362129Read ↗

The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.Semantic proximity Read ↗

An investigation of novel DNA based vaccines for protection against brucellosisSemantic proximity Read ↗

Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.Semantic proximity Read ↗

Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.Semantic proximity Read ↗

Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs.Semantic proximity Read ↗

One-step preparation of a self-assembled bioconjugate nanovaccine against BrucellaSemantic proximity Read ↗

Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.Semantic proximity Read ↗

Rev1 wbdR tagged vaccines against Brucella ovisSemantic proximity Read ↗

Enteric Pathogens as Vaccine Vectors for Foreign Antigen DeliverySemantic proximity Read ↗

Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.Semantic proximity Read ↗

Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.Semantic proximity Read ↗

A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.